Advocacy intelligence hub — real-time data for patient organizations
Bioaster — NA
Drugs for Neglected Diseases — PHASE2
Medicines Development for Global Health — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
François MISSAMOU, MD
Programme National de Lutte contre l'Onchocercose (PNLO)
Peter U Fischer, PhD
Washington University School of Medicine
Daniel A Boakye, PhD
Noguchi Memorial Institute for Medical Research
Gary J Weil, MD, M.D
Washington University School of Medicine
📍 BELLEVUE, WA
Nicholas O Opoku, MD
University of Health and Allied Sciences School of Public Health, Hohoe, Ghana
Joseph KAMGNO
ISM (Higher Institute for Scientific and Medical Research)